Judith A Woodfolk
Overview
Explore the profile of Judith A Woodfolk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bryant N, Muehling L, Wavell K, Teague W, Woodfolk J
bioRxiv
. 2024 Nov;
PMID: 39605344
Severe asthma in children is notoriously difficult to treat, and its immunopathogenesis is complex. In particular, the contribution of T cells and relationships to anti-viral immunity, remain enigmatic. Here, we...
2.
Richards N, Ailsworth S, Workman L, Bortz P, Patel J, MacCallum M, et al.
J Allergy Clin Immunol Pract
. 2024 Jun;
12(10):2817-2825.e2.
PMID: 38944197
Background: IgE to galactose-alpha-1,3-galactose (alpha-gal) is linked to tick bites and an important cause of anaphylaxis and urticarial reactions to mammalian meat. The alpha-gal syndrome (AGS) is recognized as being...
3.
Canderan G, Muehling L, Kadl A, Ladd S, Bonham C, Cross C, et al.
bioRxiv
. 2024 Apr;
PMID: 38617217
The variable etiology of persistent breathlessness after COVID-19 have confounded efforts to decipher the immunopathology of lung sequelae. Here, we analyzed hundreds of cellular and molecular features in the context...
4.
High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis
Bingham G, Muehling L, Li C, Huang Y, Ma S, Abebayehu D, et al.
Front Immunol
. 2024 Jan;
14:1308594.
PMID: 38292490
Introduction: Up to 30% of hospitalized COVID-19 patients experience persistent sequelae, including pulmonary fibrosis (PF). Methods: We examined COVID-19 survivors with impaired lung function and imaging worrisome for developing PF...
5.
Ayers E, Canderan G, Williams M, Keshavarz B, Portell C, Wilson J, et al.
Blood Cancer J
. 2023 Jul;
13(1):114.
PMID: 37495573
No abstract available.
6.
Muehling L, Heymann P, Carper H, Murphy D, Rajadhyaksha E, Kennedy J, et al.
Clin Exp Allergy
. 2022 May;
52(10):1169-1182.
PMID: 35575980
Background: Infection with rhinovirus (RV) is a major risk factor for disease exacerbations in patients with allergic asthma. This study analysed a broad set of cytokines in the noses of...
7.
Keshavarz B, Richards N, Workman L, Patel J, Muehling L, Canderan G, et al.
Front Immunol
. 2022 Apr;
13:850987.
PMID: 35386716
Three COVID-19 vaccines have received FDA-authorization and are in use in the United States, but there is limited head-to-head data on the durability of the immune response elicited by these...
8.
Barone S, Paul A, Muehling L, Lannigan J, Kwok W, Turner R, et al.
Elife
. 2021 Aug;
10.
PMID: 34350827
For an emerging disease like COVID-19, systems immunology tools may quickly identify and quantitatively characterize cells associated with disease progression or clinical response. With repeated sampling, immune monitoring creates a...
9.
Keshavarz B, Wiencek J, Workman L, Straesser M, Muehling L, Canderan G, et al.
Int Arch Allergy Immunol
. 2021 Feb;
182(5):417-424.
PMID: 33621972
Background: Detailed understanding of the immune response to severe acute respiratory syndrome coronavirus (SARS-CoV)-2, the cause of coronavirus disease 2019 (CO-VID-19) has been hampered by a lack of quantitative antibody...
10.
Keshavarz B, Wiencek J, Workman L, Straesser M, Muehling L, Canderan G, et al.
medRxiv
. 2020 Nov;
PMID: 33200147
Background: Detailed understanding of the immune response to SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), has been hampered by a lack of quantitative antibody assays. Objective: To develop a...